PepGen Inc.PEPG

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$2.68
Market cap
$185.5M
P/E
—
Revenue (TTM)
—
Net income
-$71.9M
Dividend yield
—
1-year total return
-54.4%
Net margin
—
Revenue growth
—
Debt / equity
—

What PepGen Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Net income—-$27.3M-$69.1M-$78.6M-$90.0M-$89.7M
Free cash flow—-$23.1M-$63.0M-$71.6M-$82.9M-$81.9M

More on PEPG.

Figures from PepGen Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.